glp-1 drugs pharmaceutical companies news 2025 2025’s Breakthrough Obesity Treatments: Top & Innovations GLP-1 Agonists Weight Loss Drugs

Impact of Glucagon-Like Peptide-1 Receptor Agonists on the Dementia Incidence in Patients With Type 2 Diabetes Mellitus: A Population-Based Longitudinal Cohort Study

Patients with commercial insurance plans that dont cover the drug who pay cash can receive a savings card to reduce the full list price by $500

These practical factors play a big role in how people experience treatment

adults diagnosed with obesity and roughly 35 million with Type 2 diabetes, its no wonder the popularity of GLP-1 therapies has skyrocketed, with numerous endorsements labeling them as miracle drugs. However, both doctors and patients are encountering challenges related to medication access, adherence, and insurance barriers